Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
"Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A myelodysplastic/myeloproliferative disorder characterized by myelodysplasia associated with bone marrow and peripheral blood patterns similar to CHRONIC MYELOID LEUKEMIA, but cytogenetically lacking a PHILADELPHIA CHROMOSOME or bcr/abl fusion gene (GENES, ABL).
| Descriptor ID |
D054438
|
| MeSH Number(s) |
C04.557.337.539.300 C15.378.190.615.500
|
| Concept/Terms |
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative- Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
- Chronic Myeloid Leukemia, Atypical
- Leukemia, Myelogenous, Ph1 Negative
- Leukemia, Myelogenous, Ph1-Negative
- Leukemia, Myeloid, Chronic, Atypical
- Leukemia, Myeloid, Ph1 Negative
- Leukemia, Myeloid, Philadelphia Negative
- Leukemia, Myeloid, Philadelphia-Negative
- Myelogenous Leukemia, Ph1-Negative
- Leukemia, Ph1-Negative Myelogenous
- Leukemias, Ph1-Negative Myelogenous
- Myelogenous Leukemia, Ph1 Negative
- Myelogenous Leukemias, Ph1-Negative
- Ph1-Negative Myelogenous Leukemia
- Ph1-Negative Myelogenous Leukemias
- Myeloid Leukemia, Ph1-Negative
- Leukemia, Ph1-Negative Myeloid
- Leukemias, Ph1-Negative Myeloid
- Myeloid Leukemia, Ph1 Negative
- Myeloid Leukemias, Ph1-Negative
- Ph1-Negative Myeloid Leukemia
- Ph1-Negative Myeloid Leukemias
- Myeloid Leukemia, Philadelphia-Negative
- Leukemia, Philadelphia-Negative Myeloid
- Leukemias, Philadelphia-Negative Myeloid
- Myeloid Leukemia, Philadelphia Negative
- Myeloid Leukemias, Philadelphia-Negative
- Philadelphia-Negative Myeloid Leukemia
- Philadelphia-Negative Myeloid Leukemias
- Atypical Chronic Myeloid Leukemia
- Leukemia, Myeloid, Ph1-Negative
|
Below are MeSH descriptors whose meaning is more general than "Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative".
Below are MeSH descriptors whose meaning is more specific than "Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative".
This graph shows the total number of publications written about "Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative" by people in this website by year, and whether "Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 0 | 1 |
| 1995 | 1 | 1 | 2 |
| 1996 | 0 | 1 | 1 |
| 1999 | 1 | 0 | 1 |
| 2000 | 0 | 1 | 1 |
| 2002 | 2 | 0 | 2 |
| 2004 | 2 | 0 | 2 |
| 2006 | 0 | 2 | 2 |
| 2007 | 2 | 1 | 3 |
| 2008 | 3 | 0 | 3 |
| 2011 | 2 | 0 | 2 |
| 2014 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 1 | 1 | 2 |
| 2021 | 2 | 0 | 2 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative" by people in Profiles.
-
ETNK1 mutation occurs in a wide spectrum of myeloid neoplasms and is not specific for atypical chronic myeloid leukemia. Cancer. 2023 03 15; 129(6):878-889.
-
Myelodysplastic/myeloproliferative neoplasms-unclassifiable with isolated isochromosome 17q represents a distinct clinico-biologic subset: a multi-institutional collaborative study from the Bone Marrow Pathology Group. Mod Pathol. 2022 04; 35(4):470-479.
-
Clinicopathologic correlates and natural history of atypical chronic myeloid leukemia. Cancer. 2021 09 01; 127(17):3113-3124.
-
Clonal chromosomal abnormalities appearing in Philadelphia chromosome-negative metaphases during CML treatment. Blood. 2017 11 09; 130(19):2084-2091.
-
TP53 mutation does not confer a poor outcome in adult patients with acute lymphoblastic leukemia who are treated with frontline hyper-CVAD-based regimens. Cancer. 2017 Oct 01; 123(19):3717-3724.
-
Prognostic impact of pretreatment cytogenetics in adult Philadelphia chromosome-negative acute lymphoblastic leukemia in the era of minimal residual disease. Cancer. 2017 02 01; 123(3):459-467.
-
Association of lymphoid malignancies and Philadelphia-chromosome negative myeloproliferative neoplasms: Clinical characteristics, therapy and outcome. Leuk Res. 2015 Aug; 39(8):822-7.
-
Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasms. Blood. 2014 Apr 24; 123(17):2645-51.
-
Chronic myeloid leukemia 2011: successes, challenges, and strategies--proceedings of the 5th annual BCR-ABL1 positive and BCR-ABL1 negative myeloproliferative neoplasms workshop. Am J Hematol. 2011 Sep; 86(9):811-9.
-
Philadelphia-negative classical myeloproliferative neoplasms: critical concepts and management recommendations from European LeukemiaNet. J Clin Oncol. 2011 Feb 20; 29(6):761-70.